tiprankstipranks
Redx Pharma PLC (DE:0RX)
FRANKFURT:0RX

Redx Pharma (0RX) Financial Statements

0 Followers

Redx Pharma Financial Overview

Redx Pharma's market cap is currently ―. The company's EPS TTM is €; its P/E ratio is ―; Redx Pharma is scheduled to report earnings on June 10, 2024, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 22Mar 22Sep 21Mar 21Sep 20
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT-----
EBITDA-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments£ 53.85M£ 31.58M£ 29.55M£ 39.86M£ 27.51M
Total Assets£ 62.48M£ 39.94M£ 39.55M£ 46.44M£ 32.93M
Total Debt£ 18.30M£ 17.84M£ 17.40M£ 15.99M£ 20.47M
Net Debt£ -35.55M£ -13.74M£ -12.16M£ -23.87M£ -7.04M
Total Liabilities£ 29.16M£ 34.56M£ 26.41M£ 25.13M£ 30.90M
Stockholders Equity£ 33.32M£ 5.38M£ 13.13M£ 21.32M£ 2.03M
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in GBP

Redx Pharma Earnings and Revenue History

Redx Pharma Debt to Assets

Redx Pharma Cash Flow

Redx Pharma Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis